Patents by Inventor Hongjian Wang

Hongjian Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12235972
    Abstract: The disclosure provides a security analysis method and system based on protocol state, which relates to the technical field of protocol security protection. The method includes the following: a node traversal table is built, the node traversal table is scanned and analyzed according to the protocol trigger sequence rule, a first security evaluation factor of a protocol stack is determined, and a second security evaluation factor of each protocol is determined based on protocol normal application rule, and the trustworthiness degree of the second security factor is determined based on the first security factor, and the second security factor is revised based on the trustworthiness degree, and the security state of the protocol is determined according to the revised second security factor, thus the analysis of the protocol state is realized, and the security of the protocol can be accurately determined.
    Type: Grant
    Filed: July 9, 2024
    Date of Patent: February 25, 2025
    Assignee: HUANENG INFORMATION TECHNOLOGY CO., LTD.
    Inventors: Ziqiang Wen, Hongjian Qi, Shuo Han, Chenghua Qu, Yufei Wang, Lei Xu, Zhongying Pan, Sheng Ye, Shouhui Xin, Wei Li, Yujie Liu, Qiang Zhang, Chengfeng Song, Hongwei Zhang, Yanfei Xu, Xushuai Qin, Xunan Deng
  • Patent number: 12230019
    Abstract: The present invention discloses a decoupling divide-and-conquer facial nerve segmentation method and device. As for the characteristics of a small facial nerve structure and a low contrast, a facial nerve segmentation model including a feature extraction module, a rough segmentation module, and a fine segmentation module is constructed. The feature extraction module is configured to extract a low-level feature and a plurality of different- and high-level features. The rough segmentation module is configured to globally search the different- and high-level features for facial-nerve features and fuse them. The fine segmentation module is configured to decouple a fused feature to obtain a central body feature. After the central body feature is combined with the low-level feature to obtain an edge-detail feature, a space attention mechanism is used to extract attention features from the central body feature and the edge-detail feature, to obtain a facial nerve segmentation image.
    Type: Grant
    Filed: February 28, 2022
    Date of Patent: February 18, 2025
    Assignee: ZHEJIANG UNIVERSITY
    Inventors: Jing Wang, Bo Dong, Hongjian He, Xiujun Cai
  • Publication number: 20250045417
    Abstract: The disclosure provides a security analysis method and system based on protocol state, which relates to the technical field of protocol security protection. The method includes the following: a node traversal table is built, the node traversal table is scanned and analyzed according to the protocol trigger sequence rule, a first security evaluation factor of a protocol stack is determined, and a second security evaluation factor of each protocol is determined based on protocol normal application rule, and the trustworthiness degree of the second security factor is determined based on the first security factor, and the second security factor is revised based on the trustworthiness degree, and the security state of the protocol is determined according to the revised second security factor, thus the analysis of the protocol state is realized, and the security of the protocol can be accurately determined.
    Type: Application
    Filed: July 9, 2024
    Publication date: February 6, 2025
    Applicant: HUANENG INFORMATION TECHNOLOGY CO., LTD.
    Inventors: Ziqiang WEN, Hongjian QI, Shuo HAN, Chenghua QU, Yufei WANG, Lei XU, Zhongying PAN, Sheng YE, Shouhui XIN, Wei LI, Yujie LIU, Qiang ZHANG, Chengfeng SONG, Hongwei ZHANG, Yanfei XU, Xushuai QIN, Xunan DENG
  • Patent number: 12203365
    Abstract: A method for evaluating rock drillability by a nano-indentation test on a rock cutting includes: conducting a nano-indentation test on a rock cutting sample, acquiring a displacement-load curve of an indenter, and calculating a micro-hardness under the nano-indentation test; calculating mineral composition of the rock cutting sample based on a statistical distribution characteristic of the micro-hardness, and transforming the micro-hardness under the nano-indentation test on the rock cutting sample into a macro-hardness; and calculating a rock drillability grade characterized by the micro-hardness under the nano-indentation test on the rock cutting sample based on a correlation between the macro-hardness of the rock cutting sample and the rock drillability grade. In the context of few downhole rock samples and high cost, the method overcomes the limitation of sample size and shape on conventional testing and solves the difficult problem of mechanical parameter testing of deep rocks.
    Type: Grant
    Filed: August 9, 2022
    Date of Patent: January 21, 2025
    Assignee: CHINA UNIVERSITY OF PETROLEUM (EAST CHINA)
    Inventors: Zizhen Wang, Xianbo Lei, Weidong Zhou, Chengwen Wang, Ruihe Wang, Xian Shi, Luopeng Li, Hongjian Ni, Rui Zhang
  • Patent number: 12187710
    Abstract: Provided is a salt of an Syk inhibitor and a crystalline form thereof, and more specifically, provided are 5-fluoro-1-methyl-3-((5-(4-(oxetan-3-yl)piperazine-1)-yl)pyridin-2-yl)amino)-6-(1H-pyrazol-3-yl)quinoline-2(1H)-ketamine hydrochloride, a crystalline form thereof, a preparation method therefor, a pharmaceutical composition thereof and a use thereof. The hydrochloride of the compound represented by formula I and the crystalline form thereof have good salt-forming properties, high stability and low hygroscopicity, have advantages in terms of physical properties, safety and metabolic stability, and have value in prepared medicines.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: January 7, 2025
    Assignee: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Wenyuan Qian, Hongjian Wang, Ming Zhang, Fei Liu, Lei Xing, Zhongyuan Hu, Yahui Guo, Yanlong Liu, Huihui Zhang
  • Publication number: 20240132503
    Abstract: Provided are a salt form and a crystal form of a pyrazole substituted imidazo[1,2-a]quinoxaline derivative, and a preparation method therefor. Specifically disclosed are a salt form and a crystal form of a compound of formula (I), and a preparation method therefor and the use thereof in the preparation of drugs related to dual inhibitors of spleen tyrosine kinase (Syk) and vascular endothelial growth factor 2 (VEGFR2).
    Type: Application
    Filed: January 12, 2022
    Publication date: April 25, 2024
    Inventors: Wenyuan QIAN, Hongjian WANG, Liang TAN, Shuhui CHEN
  • Patent number: 11958779
    Abstract: The MnZn ferrite material includes principal components and auxiliary components, where the principal components include: 52.5 mol % to 53.8 mol % of Fe2O3, 8.8 mol % to 12 mol % of ZnO, and the balance of MnO; the auxiliary components include: 0.35 wt % to 0.5 wt % of Co2O3, 0.03 wt % to 0.08 wt % of CaSiO3, 0.01 wt % to 0.04 wt % of Nb2O5, and 0.05 wt % to 0.12 wt % of TiO2 and RE elemental components; the RE elemental components include one or more from the group consisting of 0 wt % to 0.04 wt % of Gd2O3, 0 wt % to 0.02 wt % of Ho2O3, and 0 wt % to 0.03 wt % of Ce2O3; the auxiliary components are all represented by a mass percentage relative to a total mass of the Fe2O3, the MnO, and the ZnO.
    Type: Grant
    Filed: September 24, 2021
    Date of Patent: April 16, 2024
    Assignee: TDG HOLDING CO., LTD
    Inventors: Hongjian Wang, Bingbing Xing, Yanfeng Huang, Qiangyuan Zhang, Zhixin Zhang
  • Publication number: 20230219960
    Abstract: A class of spleen tyrosine kinase (Syk) and vascular endothelial growth factor 2 (VEGFR2) dual inhibitors, and specifically disclosed are a compound represented by formula (I), a pharmaceutically acceptable salt thereof, and an application thereof in the preparation of a Syk and VEGFR2 dual inhibitor related drug.
    Type: Application
    Filed: February 23, 2021
    Publication date: July 13, 2023
    Inventors: Wenyuan Qian, Hongjian Wang, Liang Tan, Shuhui Chen
  • Publication number: 20230191272
    Abstract: An inflatable model with lighting effects includes a light-transmissive inflatable body, an air supply component for inflating the interior of the light-transmissive inflatable body, and a main light source which emits light from the interior of the light-transmissive inflatable body. The light-transmissive inflatable body is divided into a plurality of decoration areas. Each decoration area is provided with at least one effect light source. According to the present invention, various lighting effect combinations on the inflatable model can be achieved, thus enriching the exhibition effect of the inflatable model. Therefore, the inflatable model in the present invention can attract attention of people more easily and is more suitable for activity meeting places with diversified lighting effect requirements such as Halloween, Christmas, and the like.
    Type: Application
    Filed: January 31, 2022
    Publication date: June 22, 2023
    Inventor: Hongjian WANG
  • Publication number: 20230128137
    Abstract: A benzo five-membered cyclic compound represented by formula (I) or a pharmaceutically acceptable salt thereof has a significant effect in inhibiting the activity of anti-apoptotic Bcl-2 protein.
    Type: Application
    Filed: March 8, 2021
    Publication date: April 27, 2023
    Inventors: Hongjian WANG, Wenyuan QIAN, Ming ZHANG, Jian LI, Shuhui CHEN
  • Patent number: 11468570
    Abstract: The present application relates to a method for acquiring maximum principal strain or a maximum principal stress status of a vessel wall.
    Type: Grant
    Filed: September 10, 2020
    Date of Patent: October 11, 2022
    Assignee: SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.
    Inventors: Hongjian Wang, Jieyan Ma, Yuan Ren
  • Publication number: 20220180351
    Abstract: This application provides a communications system (100) for automatically selecting an NFC emulation card, which includes an NFC card reader (102) and an electronic device (101). The NFC card reader (102) sends third query information which includes first identification information and a service type of an emulation card. The electronic device (101) determines whether a first emulation card exists. When determining that the first emulation card exists, the electronic device (101) determines whether a second emulation card exists. When determining that the second emulation card exists, the electronic device (101) sends fourth response information which carries second identification information. The NFC card reader (102) sends card selection instruction information. The electronic device (101) receives the card selection instruction information, and sends card selection response information.
    Type: Application
    Filed: March 6, 2020
    Publication date: June 9, 2022
    Inventors: Yun ZHOU, Yongwei WANG, Xiang LI, Hongjian WANG
  • Publication number: 20220017498
    Abstract: Provided is a salt of an Syk inhibitor and a crystalline form thereof, and more specifically, provided are 5-fluoro-1-methyl-3-((5-(4-(oxetan-3-yl)piperazine-1)-yl)pyridin-2-yl)amino)-6-(1H-pyrazol-3-yl)quinoline-2(1H)-ketamine hydrochloride, a crystalline form thereof, a preparation method therefor, a pharmaceutical composition thereof and a use thereof. The hydrochloride of the compound represented by formula I and the crystalline form thereof have good salt-forming properties, high stability and low hygroscopicity, have advantages in terms of physical properties, safety and metabolic stability, and have value in prepared medicines.
    Type: Application
    Filed: December 13, 2019
    Publication date: January 20, 2022
    Inventors: Wenyuan QIAN, Hongjian WANG, Ming ZHANG, Fei LIU, Lei XING, Zhongyuan HU, Yahui GUO, Yanlong LIU, Huihui ZHANG
  • Publication number: 20220009837
    Abstract: The MnZn ferrite material includes principal components and auxiliary components, where the principal components include: 52.5 mol % to 53.8 mol % of Fe2O3, 8.8 mol % to 12 mol % of ZnO, and the balance of MnO; the auxiliary components include: 0.35 wt % to 0.5 wt % of Co2O3, 0.03 wt % to 0.08 wt % of CaSiO3, 0.01 wt % to 0.04 wt % of Nb2O5, and 0.05 wt % to 0.12 wt % of TiO2 and RE elemental components; the RE elemental components include one or more from the group consisting of 0 wt % to 0.04 wt % of Gd2O3, 0 wt % to 0.02 wt % of HO2O3, and 0 wt % to 0.03 wt % of Ce2O3; the auxiliary components are all represented by a mass percentage relative to a total mass of the Fe2O3, the MnO, and the ZnO.
    Type: Application
    Filed: September 24, 2021
    Publication date: January 13, 2022
    Applicant: TDG HOLDING CO., LTD
    Inventors: Hongjian WANG, Bingbing XING, Yanfeng HUANG, Qiangyuan ZHANG, Zhixin ZHANG
  • Patent number: 11091460
    Abstract: Provided are a Syk inhibitor and a use method therefor, and in particular, disclosed are quinolinone represented by formula (I) or quinazoline derivatives or pharmaceutically acceptable salts thereof, a preparation method, a pharmaceutical composition, and uses in preparing a medicament for treatment of Syk receptor related diseases.
    Type: Grant
    Filed: June 14, 2018
    Date of Patent: August 17, 2021
    Assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
    Inventors: Shilan Liu, Guibai Liang, Hongjian Wang, Ming Zhang, Shuhui Chen
  • Publication number: 20210132906
    Abstract: Disclosed is a method for configuring an MSD parallel adder based on ternary logic operators. Five ternary logic operators that satisfy a sufficient condition for MSD addition are used to configure an MSD parallel adder. During the arrangement of a ternary logic operator, any method in the following may be used: each of ternary operators of n bits is reconfigured into a ternary logic operator each time, and reconfiguration is performed five times for implementation; each of ternary operators of n bits is reconfigured into two ternary logic operators having the same input each time, and reconfiguration is performed three times for implementation; each of ternary operators of n bits is reconfigured into five ternary logic operators of the same time, and reconfiguration is performed once for implementation; corresponding unreconfigurable ternary logic operators are used instead for the foregoing reconfiguration process.
    Type: Application
    Filed: December 11, 2020
    Publication date: May 6, 2021
    Inventors: Yi JIN, Yunfu SHEN, Shan OUYANG, Junjie PENG, Junjie ZHANG, Hongjian WANG
  • Publication number: 20200410685
    Abstract: The present application relates to a method for acquiring maximum principal strain or a maximum principal stress status of a vessel wall.
    Type: Application
    Filed: September 10, 2020
    Publication date: December 31, 2020
    Applicant: SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.
    Inventors: Hongjian WANG, Jieyan MA, Yuan REN
  • Patent number: D1014320
    Type: Grant
    Filed: January 25, 2022
    Date of Patent: February 13, 2024
    Inventor: Hongjian Wang
  • Patent number: D1024837
    Type: Grant
    Filed: January 21, 2022
    Date of Patent: April 30, 2024
    Inventor: Hongjian Wang
  • Patent number: D1056048
    Type: Grant
    Filed: August 29, 2022
    Date of Patent: December 31, 2024
    Assignee: SHENZHEN BAIYI TECHNOLOGY CO., LTD.
    Inventor: Hongjian Wang